OPTI-AML: PROSPECTIVE RANDOMIZED PHASE 2 TRIAL OF 28 VERSUS 14 DAY SCHEDULE OF VENETOCLAX AND AZACITIDINE FOR 2 CYCLES IN NEWLY DIAGNOSED GENOMICALLY AGNOSTIC ACUTE MYELOID LEUKEMIA PATIENTS ≥60 YEARS

EHA Library, Uma Borate, 4206680

VENETOCLAX AND AZACITIDINE FOR MOLECULAR FAILURE INTERVENTION AS A BRIDGE-TO-TRANSPLANT STRATEGY FOR NPM1-MUTATED ACUTE MYELOID LEUKEMIA: THE GIMEMA AML2521 PHASE 2 TRIAL

EHA Library, Chiara Sartor, 4206682

TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND MINIMAL RESIDUAL DISEASE AT THE END OF FRONTLINE CONSOLIDATION

EHA Library, Shannon Maude, 4206689

RESOLVING THE TUMOR HETEROGENEITY OF CLL SUBSET #8 AT SINGLE-CELL RESOLUTION: INSIGHTS INTO CLONAL DYNAMICS AND DISTINCT SUB-CLONAL MUTATIONAL LANDSCAPES

EHA Library, Athanasios Roussos, 4206696

PONATINIB CONSOLIDATION AND DISCONTINUATION IN CML PATIENTS AFTER FAILED FIRST TFR ATTEMPT: UPDATED TFR OUTCOMES AND CHIP MUTATION ANALYSIS FROM THE RESTOP TRIAL

EHA Library, Gonzalo CARRENO, 4206715

HIGH RATES OF SUCCESSFUL SECOND STOP ATTEMPTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: RESULTS OF THE NAUT TRIAL

EHA Library, Katharina Kohlbrenner, 4206716

CLONAL ARCHITECTURE AND DYNAMICS OF SOMATIC EVOLUTION IN APLASTIC ANEMIA AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Kudzai Nyamondo, 4206729

IN VIVO LENTIVIRAL GENE TRANSFER INTO HEMATOPOIETIC STEM CELLS FOR THE TREATMENT OF FANCONI ANEMIA

EHA Library, Michela Milani, 4206730

DISTINCT IMMUNE DIVERSITY OF CD8+ T CELLS DEFINES PEDIATRIC HEPATITIS-ASSOCIATED APLASTIC ANEMIA AND SEVERE APLASTIC ANEMIA

EHA Library, Lixian Chang, 4206731

LONG-TERM OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY SEVERE APLASTIC ANEMIA

EHA Library, Fieke Hoff, 4206732

EARLY BONE FRAGILITY IS ASSOCIATED WITH VASCULAR ABNORMALITIES IN TELOMERE BIOLOGY DISORDERS: FINDINGS FROM THE MULTICENTER, INTERNATIONAL INSIGHT STUDY

EHA Library, Jane Koo, 4206733

SUCCESSFUL IN VIVO CAR-T GENERATION AND MINIMAL RESIDUAL DISEASE (MRD) CLEARANCE WITH KLN-1010 ACROSS DIVERSE BASELINE T CELL PHENOTYPES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Andrew Spencer, 4206739

THE DYNAMIC LANDSCAPE OF IMMUNE ENVIRONMENT FOR MM PATIENTS RECEIVING T CELL REDIRECTING THERAPIES

EHA Library, Haimeng Li, 4206740

AZD0120, A DUAL BCMA/CD19 CAR-T CELL THERAPY, DEMONSTRATES A NAIVE/CENTRAL MEMORY PHENOTYPE AND INDUCES A RAPID DECLINE IN SOLUBLE BCMA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Binod Dhakal, 4206741

DEVELOPMENT OF BMS-986453, A DUAL-TARGETING BCMA×GPRC5D CHIMERIC ANTIGEN RECEPTOR (CAR) FOR THE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Doris Hansen, 4206742

BTL-101, A FULLY HUMAN TRISPECIFIC BCMA×GPRC5D×CD3 T-CELL ENGAGER FOR THE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Jiansong Yang, 4206743

SAFETY AND EFFICACY OF SUBCUTANEOUS MOSUNETUZUMAB PLUS LENALIDOMIDE INDUCTION THERAPY FOLLOWED BY MOSUNETUZUMAB MAINTENANCE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA

EHA Library, Emmanuel Bachy, 4206780

SUROVATAMIG (AZD0486) PLUS RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (FL): INITIAL SAFETY DATA FROM THE PHASE 3 SOUNDTRACK-F1 TRIAL

EHA Library, Chan Y. Cheah, 4206782

CLINICALLY RELEVANT SUBGROUP ANALYSIS FROM THE RANDOMIZED PHASE 3 EPCORE FL-1 TRIAL: TREATMENT (TX) EFFECT OF EPCORITAMAB WITH LENALIDOMIDE AND RITUXIMAB (R²) IN R/R FOLLICULAR LYMPHOMA (FL)

EHA Library, Benoit Tessoulin, 4206783

CLINICAL, GENETIC, AND IMMUNE MICROENVIRONMENTAL LANDSCAPES OF PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA: A COMPARATIVE STUDY WITH NODAL AND IMMUNE-PRIVILEGED SITE DLBCL

EHA Library, Junlei Jia, 4206801

BRENTUXIMAB VEDOTIN PLUS CHP PLUS ETOPOSIDE (CHEPA) IN NEWLY DIAGNOSED CD30- POSITIVE PERIPHERAL T-CELL LYMPHOMAS WITH INTEGRATED CTDNA ANALYSIS: PRIMARY RESULTS OF THE PHASE 2 CHEPA TRIAL.

EHA Library, Marek Trněný, 4206802

HIGH-DOSE METHOTREXATE DOES NOT REDUCE RISK OF CNS RELAPSE IN ULTRA HIGH-RISK LARGE B-CELL LYMPHOMA: AN INTERNATIONAL RETROSPECTIVE ANALYSIS OF 1,923 PATIENTS

EHA Library, Matthew R. Wilson, 4206803

DEVELOPMENT AND VALIDATION OF THE FAC-HCT SCALE (FRAILTY, AGE AND COMORBIDITY) TO PREDICT OVERALL SURVIVAL AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Maria Queralt Salas, 4206819

DONOR AGE DOES NOT AFFECT OUTCOMES OF HAPLOIDENTICAL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: A STUDY BASED ON THE CHINESE BONE MARROW TRANSPLANTATION REGISTRY GROUP (CBMTRG)

EHA Library, Xuechun Wang, 4206823

A TIME-RESOLVED SINGLE‑NUCLEUS MULTIOME ATLAS OF HUMAN FETAL LIVER HEMATOPOIESIS

EHA Library, Yiwei Niu, 4206830

MITOCHONDRIAL DNA MOSAICISM AND CLONALITY IN HUMAN HEMATOPOIETIC AGING AND REGENERATION

EHA Library, Ambre Giguelay, 4206832

MAPPING HEMATOPOIETIC STEM CELL NICHE INTERACTIONS AT SINGLE-CELL AND CLONAL RESOLUTION IDENTIFIES ALTERED CROSSTALK AND NOVEL TARGETS: Β-THALASSEMIA AS A CASE STUDY OF INHERITED BLOOD DISORDERS

EHA Library, Annamaria Aprile, 4206833

THE PREDIC-TO STUDY: AN INTERNATIONAL, REAL-WORLD COHORT STUDY OF VENOUS THROMBOEMBOLISM RISK MODEL STRATIFICATION IN DLBCL PATIENTS ACROSS ASIA, EUROPE, AND UNITED STATES OF AMERICA

EHA Library, Giulia Bassi, 4206891

TEMPORAL TRENDS IN HEPATITIS B RISK FOLLOWING LYMPHOMA: A POPULATION-BASED ANALYSIS USING SWEDISH LYMPHOMA REGISTRY DATA (2002–2024)

EHA Library, Torsten Dahlén, 4206892

PROSPECTIVE VALIDATION OF A WEIGHTED GAH SCORE IN PATIENTS ≥65 YEARS WITH LYMPHOPROLIFERATIVE NEOPLASMS: TOXICITY PREDICTION AND PROGNOSTIC IMPACT

EHA Library, Josefa Marco Buades, 4206894

TREATMENT ACCESS ELIMINATES RACIAL DISPARITIES BUT CANNOT OVERCOME STRUCTURAL POVERTY: A NATIONAL ANALYSIS OF SURVIVAL EQUITY IN CURABLE LYMPHOMA

EHA Library, Shivam Patel, 4206895

EPCORITAMAB + R-MINI-CHOP RESULTS IN 2-YEAR REMISSIONS AND HIGH MRD-NEGATIVITY RATES IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL: RESULTS FROM THE EPCORE NHL-2 TRIAL

EHA Library, David Belada, 4206896

ADDITION OF HIGH-DOSE METHOTREXATE TO STANDARD FIRST-LINE IMMUNOCHEMOTHERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IS ASSOCIATED WITH ACUTE BUT NOT CHRONIC KIDNEY DISEASE

EHA Library, Silje Post Strøm, 4206897

DEVELOPMENT AND VALIDATION OF A CLINICOPATHOLOGICAL PROGNOSTIC MODEL FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Yupiao Feng, 4206900

DEVELOPMENT OF A PROGNOSTIC MODEL INCORPORATING PLASMA EBV-DNA LEVEL FOR EBV-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, SINGLE-CENTER STUDY

EHA Library, Xinzhu Tang, 4206902

REAL-WORLD (RW) TREATMENT PATTERNS AND SURVIVAL OUTCOMES IN PATIENTS (PTS) WITH NEWLY DIAGNOSED HIGH-RISK (HR) LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Javier Munoz, 4206903

THE CLINICAL SIGNIFICANCE OF MYC::BCL6 FUSION IN MYC/BCL6 DOUBLE HIT LYMPHOMA PATIENTS

EHA Library, Shaoying Li, 4206905

MULTIVARIABLE ANALYSES OF OVERALL SURVIVAL IN THE PHASE 3 SUNMO, STARGLO AND POLARGO TRIALS IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Matthew Matasar, 4206907

IMMUNE DEFICIENCY AND INFECTION RISK FOLLOWING  SECOND LINE CAR-T CELLS THERAPY IN RELAPSED REFRACTORY LARGE B CELLS LYMPHOMA

EHA Library, Mohamad Sabbah, 4206908

OUTCOMES OF CONSOLIDATIVE RADIOTHERAPY AND SURVIVAL IN LIMITED-STAGE PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA ACHIEVING COMPLETE RESPONSE: A MULTICENTER STUDY FROM CHINA

EHA Library, Natalia Sunarto, 4206910

INTERNATIONAL EXPERT CONSENSUS ON REAL-WORLD CAR T-CELL ELIGIBILITY IN LARGE B-CELL LYMPHOMAS: AN E-DELPHI STUDY

EHA Library, Catherine Thieblemont, 4206912

REAL-WORLD MANAGEMENT AND OUTCOMES OF PTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA: INSIGHTS FROM THE FRENCH REALYSA COHORT.

EHA Library, Loic Renaud, 4206923

CHIDAMIDE IN COMBINATION WITH CHOP IN PREVIOUSLY UNTREATED PERIPHERAL T-CELL LYMPHOMA WITH T FOLLICULAR HELPER PHENOTYPE–RESULTS OF PHASE II SWIFT TRIAL

EHA Library, Qingqing Cai, 4206925

THE AITL-HZ SCORE INCORPORATING EBV AND COMPLEMENT C3 OUTPERFORMS EXISTING PROGNOSTIC MODELS FOR CHINESE AITL PATIENTS

EHA Library, Mengmeng Dong, 4206926

BLOOD CANCER ASSOCIATED HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IS MORE LIKELY IN YOUNGER PATIENTS, AND ONLY AGE AND T-, NKT- AND NK-CELL LYMPHOMA DIAGNOSIS IMPACT SURVIVAL.

EHA Library, Mark Bishton, 4206927

COMPARABLE EFFICACY AND SAFETY OF BRENTUXIMAB VEDOTIN -BASED THERAPY TO THE ECHELON TRIALS: REAL-WORLD EVIDENCE FROM THE BRAVE STUDY

EHA Library, Mingci Cai, 4206928

TABELECLEUCEL FOR ALLOGENEIC OR SOLID ORGAN TRANSPLANT RECIPIENTS WITH EBV+ PTLD AFTER FAILURE OF RITUXIMAB OR RITUXIMAB PLUS CHEMOTHERAPY: PAEDIATRIC SUBGROUP ANALYSIS OF THE PHASE 3 ALLELE STUDY

EHA Library, Pere Barba, 4206930

MOLECULAR LANDSCAPE OF PEDIATRIC B-CELL LYMPHOBLASTIC LYMPHOMA

EHA Library, Ekaterina Romanenko, 4206933

REAL-WORLD CHARACTERISTICS AND SURVIVAL OUTCOMES OF AGGRESSIVE NATURAL KILLER CELL LEUKEMIA IN THE UNITED STATES

EHA Library, Cher Ying Foo, 4206935

FINAL RESULTS OF A PHASE II STUDY OF THE ANTI-PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) ANTIBODY ATEZOLIZUMAB IN RELAPSED/REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA: THE NCCH1903/ATTACK STUDY

EHA Library, Shinichi Makita, 4206938

REAL-WORLD OUTCOMES OF PERIPHERAL AND CUTANEOUS T-CELL LYMPHOMAS IN KAZAKHSTAN: A NATIONWIDE MULTICENTER STUDY

EHA Library, Ayazhan Umutbayeva, 4206943

PHASE IB STUDY OF SHR0302 PLUS SHR2554 IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA: SAFETY RUN-IN AND INITIAL EFFICACY

EHA Library, Rong Tao, 4206946

TARGETING TNFR2 WITH BI-1808 WITH OR WITHOUT PEMBROLIZUMAB: IMMUNE ACTIVATION AND PROMISING RESPONSES IN ADVANCED CUTANEOUS T-CELL LYMPHOMAS

EHA Library, Stefan Barta, 4206947

MENDELIAN RANDOMIZATION REVEALS THE CAUSATIVE ROLE OF GENETICALLY PREDICTED VIRAL INFECTION IN PAN-LYMPHOMA RISK

EHA Library, Haiwen Huang, 4206949

TOTAL METABOLIC TUMOR VOLUME AND CIRCULATING TUMOR DNA AS EARLY PROGNOSTIC FACTORS IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM THE PHASE 3 STARGLO TRIAL

EHA Library, William Townsend, 4206950

EARLY OUTCOME PREDICTION OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS USING ON-TREATMENT OMICS DATA

EHA Library, Tom van den Bosch, 4206952

REDUCED CD20 EXPRESSION AND INTRATUMORAL CD3+ T CELLS FOLLOWING EPCORITAMAB TREATMENT ARE ASSOCIATED WITH PROGRESSIVE DISEASE IN A SUBSET OF DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA

EHA Library, Monica Wielgos-Bonvallet, 4206958

PHASE 3 INMIND TRIAL OF TAFASITAMAB (TAFA) PLUS LENALIDOMIDE (LEN) AND RITUXIMAB (R) IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): ANALYSES OF BIOMARKERS PREDICTIVE OF PATIENT (PT) RESPONSE

EHA Library, Diana Alvarez Arias, 4206964

INTEGRATED SNV/CNV PROFILING AT DIAGNOSIS IN MANTLE CELL LYMPHOMA IDENTIFIES GENOMIC CORRELATES OF CLINICAL HETEROGENEITY AND OUTCOME

EHA Library, Jana Karolová, 4206965

RHOA IS ESSENTIAL FOR NPM-ALK-DRIVEN LYMPHOMAGENESIS AND REPRESENTS A PROMISING THERAPEUTIC TARGET IN ALK+ ALCL

EHA Library, Claudia Voena, 4206966

GENETIC ALTERATIONS IN PEDIATRIC B-CELL NON-HODGKIN LYMPHOMA IN PATIENTS WITH INBORN ERRORS OF IMMUNITY

EHA Library, Sara Mato, 4206969

SINGLE-CELL RNA SEQUENCING REVEALS THE TUMOR MICROENVIRONMENT AND MOLECULAR FEATURES OF MALIGNANT T CELLS IN ADVANCED CUTANEOUS T-CELL LYMPHOMA

EHA Library, Jieting Wang, 4206972

RELAPSE IN PEDIATRIC ALK⁺ ALCL IS ASSOCIATED WITH EARLY INFLAMMATORY SIGNALING AND TUMOR MICROENVIRONMENT REMODELING

EHA Library, Rebekka Salzmann, 4206973

PATIENT-DERIVED LYMPHOMA SPHEROIDS AS PRECLINICAL MODELS FOR PREDICTING PATIENT RESPONSES TO ADVANCED THERAPIES IN B-NHL: EXAMPLE OF GLOFITAMAB IN FOLLICULAR LYMPHOMA

EHA Library, christine Bezombes, 4206974

PATIENTS WITH T CELLS MAINTAINING AN IMMUNE SIGNATURE FEATURING EARLY DIFFERENTIATION STAGE EXHIBIT A SUPERIOR CLINICAL RESPONSE TO PEMBROLIZUMAB IN RELAPSED LOW-GRADE LYMPHOMA

EHA Library, Zhi-Zhang Yang, 4206981

DIOSCIN INHIBITS DIFFUSE LARGE B-CELL LYMPHOMA BY MODULATING ACACA-DEPENDENT HISTONE H3K27 ACETYLATION AND INDUCING MITOPHAGY

EHA Library, Qianqian Guo, 4206984

INTEGRATED MOLECULAR AND METABOLIC PROFILING IDENTIFIES DETERMINANTS OF OUTCOME WITH LONCASTUXIMAB TESIRINE IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Ciro Maria Improta, 4206985

DURABLE RESPONSES WITH RONDECABTAGENE AUTOLEUCEL (DUAL-TARGETING CD19/CD20 CAR T-CELLS) ARE ASSOCIATED WITH HIGHER PROPORTION OF CYTOTOXIC T CELLS WITH MEMORY POTENTIAL IN INFUSION PRODUCTS

EHA Library, Akil Merchant, 4206986

TAXONOMIC AND FUNCTIONAL INTESTINAL MICROBIOME PROFILES DISTINGUISH MANTLE CELL LYMPHOMA PATIENTS FROM CONTROLS AND PERSIST ACROSS DISEASE STATES

EHA Library, Justin Desroches, 4206987

CLINICAL AND MOLECULAR CHARACTERISTICS AND THEIR IMPACT ON PROGNOSIS IN CHINESE PEDIATRIC MATURE B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Qinlong Zheng, 4206989

THE NEUROENDOCRINE-METABOLIC-IMMUNE AXIS IN B-CELL LYMPHOMA: ROLE OF ACBP/DBI IN GLUCOCORTICOID RESISTANCE AND IMMUNOSUPPRESSION

EHA Library, Hui PAN, 4206991

EPIGENETIC MODULATION ENABLES EXPANSION OF FUNCTIONAL HUMAN HSPCS IN A CHEMICALLY DEFINED SYSTEM FOR CELL AND GENE CLINICAL APPLICATIONS

EHA Library, Nobuchika Yamamoto, 4207001

EARLIER EMERGENCE OF PROLIFERATIVE CD8+ T CELLS IS ASSOCIATED WITH IMPROVED PROGNOSIS IN R/R DLBCL PATIENTS TREATED WITH AUTO-HSCT PLUS UMBILICAL CORD BLOOD INFUSION

EHA Library, Zhengchang He, 4207002

PROLIFERATING TCF1LOW PD-1HIGH POPULATION IN HUMAN CD8+ T-CELLS IS ASSOCIATED WITH THE ONSET OF AGVHD AND SUPPRESSED BY PTCY

EHA Library, Kazuya Asano, 4207003

IMPACT OF EARLY POST-TRANSPLANT MEASURABLE RESIDUAL DISEASE ON OUTCOMES OF PATIENTS WITH RELAPSED/ REFRACTORY AML: A POST-HOC ANALYSIS OF THE PROSPECTIVE ASAP TRIAL

EHA Library, Katharina Egger-Heidrich, 4207004

PHASE II STUDY OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH AUTOLOGOUS CD19-CAR T CELL INFUSION IN ADULTS WITH HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CLINICAL OUTCOMES

EHA Library, Rongli Zhang, 4207008

LONG-TERM EFFICACY AND SAFETY OF DONOR-DERIVED CAR-T CELLS INTEGRATED INTO ALLOGENEIC HSCT CONDITIONING FOR ULTRA-HIGH-RISK R/R B-NHL, T-LBL, AND MULTIPLE MYELOMA: A 5-YEAR FOLLOW-UP STUDY

EHA Library, Fan Yang, 4207009

INTEGRATING IMS–IMWG GENOMIC RISK WITH R2-ISS IMPROVES RISK STRATIFICATION IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA

EHA Library, Oren Pasvolsky, 4207011

GENETIC ABNORMALITIES INFLUENCE THE PROGNOSTIC VALUE OF PRE-TRANSPLANT MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA: A MULTICENTRE STUDY

EHA Library, Yue Jin, 4207012

CPX-351 BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION, A REAL-WOLRD FRENCH EXPERIENCE

EHA Library, Eléonore Kaphan, 4207019

IMMUNOSUPPRESSIVE STRATEGY USING LOW-DOSE ATG COMBINED WITH ANTI-CD25 ANTIBODY FOR GVHD PROPHYLAXIS IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiaosheng Fang, 4207020

THE COMBINATION OF RUXOLITINIB AND EXTRACORPOREAL PHOTOPHERESIS IS A HIGHLY EFFECTIVE SECOND LINE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Andrea Varkonyi, 4207026

EXPLORATION OF A NOVEL AGVHD PROPHYLAXIS REGIMEN BASED ON GECACITINIB IN THE PERITRANSPLANT PERIOD OF PATIENTS WITH MYELOFIBROSIS: A PILOT OPEN-LABEL STUDY

EHA Library, Na Xu, 4207029

LONGITUDINAL TCR SEQUENCING REVEALS DONOR-DEPENDENT IMMUNE RECONSTITUTION PATTERNS AFTER PEDIATRIC ALLOGENEIC HSCT FOR PRIMARY IMMUNODEFICIENCIES

EHA Library, Guanghua Zhu, 4207030

DONOR-DERIVED CYTOGENETIC ALTERATIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE SINGLE-CENTER COHORT STUDY

EHA Library, Corinne Widmer, 4207031

TREATED WITH EMAPALUMAB AS A BRIDGE TO HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY/RECURRENT EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Na Wei, 4207034

A PHASE II STUDY OF A BUSULFAN IN COMBINATION WITH FLAG CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETC STEM CELL TRANSPLANTATION

EHA Library, Xiawei Zhang, 4207035

LONGITUDINAL ASSESSMENT OF COMPLEMENT FACTOR BA AND CLINICAL RESPONSE IN ADULT TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

EHA Library, Min Wu, 4207037

TRANSPLANTATION STRATEGIES FOR LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-A MULTICENTER, REALWORLD STUDY

EHA Library, Jiexian Ma, 4207038

A PROSPECTIVE COHORT STUDY: THE ASSOCIATION BETWEEN NUTRITIONAL STATUS OF HSCT PATIENTS BEFORE TRANSPLANTATION AND EARLY INFECTION AND NON-RELAPSE MORTALITY

EHA Library, Weiwei Qin, 4207041

PIRCHE SCORES AND RECIPIENT HLA-B LEADER INFLUENCE RELAPSE AND CHRONIC GVHD AFTER 9/10 UNRELATED DONOR ALLO-HCT WITH CLASS I MISMATCH

EHA Library, Rodrigo Gil Manso, 4207043

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN OLDER ADULTS: CLINICAL OUTCOMES AND INNOVATIVE USE OF PRE-EMPTIVE DONOR LYMPHOCYTE INFUSIONS

EHA Library, Davide Stella, 4207045

DEEP LEARNING–BASED PREDICTION OF CD34⁺ CELL MOBILIZATION IN HEALTHY DONORS: AN EXPLAINABLE ARTIFICIAL NEURAL NETWORK MODEL WITH SUPERIOR PREDICTIVE PERFORMANCE

EHA Library, Bedrettin Orhan, 4207046

MEASURABLE RESIDUAL DISEASE (MRD) EVALUATION AND OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNDERGOING THEIR SECOND ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Jule Ussmann, 4207047

EVALUATION OF THE EAM CONDITIONING REGIMEN IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HODGKIN LYMPHOMA

EHA Library, Amal Bendimerad, 4207053

KANGFUXIN COMBINED WITH G-CSF ICE-CUBE CRYOTHERAPY EFFECTIVELY PREVENTS THIOTEPA-BASED CONDITIONING–INDUCED ORAL MUCOSITIS IN ALLOGENEIC HSCT: A PROSPECTIVE OPEN-LABEL COHORT STUDY

EHA Library, Li Wang, 4207054

IMMUNE RECONSTITUTION KINETICS AND CLINICAL OUTCOMES AFTER ALLOGENEIC HSCT FOR CHRONIC MYELOMONOCYTIC LEUKEMIA: A MATCHED VERSUS HAPLOIDENTICAL DONOR COMPARISON

EHA Library, Mengtong Zang, 4207056

UMBILICAL CORD BLOOD MONONUCLEAR CELL INFUSION FOR SECONDARY POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PHASE I DOSE-ESCALATION STUDY

EHA Library, Yigeng Cao, 4207057

HIGH‑SENSITIVITY NEXT GENERATION SEQUENCING (HS-NGS)-MEASURABLE RESIDUAL DISEASE (MRD) ASSAY AT DAY +100 POST‑ ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (ALLO-HCT) PREDICTS RELAPSE RISK IN AML AND MDS

EHA Library, Madiha Iqbal, 4207060

EARLY IMMUNE RECONSTITUTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN AML: ASSOCIATION WITH FLT3 STATUS AND POST-TRANSPLANT MIDOSTAURIN MAINTENANCE

EHA Library, Nevena Bešević, 4207062